The plurality of payers' perspectives on hematopoietic stem cell transplantation.
This review focuses on the economic considerations of pediatric hematopoietic stem cell transplantation from the perspective of the myriad stakeholders: patients and their families; institutions providing care; and employers/payers who are covering its costs. The article is organized by phase of transplant and by component of cost. In addition to referenced peer-reviewed literature, preliminary empirical data are also included with which to understand the cost implications. Areas of future research are identified.